Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Peritoneal Neoplasms 9Ovarian Neoplasms 8Fallopian Tube Neoplasms 5Colorectal Neoplasms 5Carcinoma, Ovarian Epithelial 3Stomach Neoplasms 2Mesothelioma 2Adrenocortical Carcinoma 2Pseudomyxoma Peritonei 1Neoplasms 1Neoplasm Metastasis 1Hyperthermia 1Gastrointestinal Neoplasms 1Gastric Adenocarcinoma 1Colonic Neoplasms 1Clear-cell metastatic renal cell carcinoma 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Brenner Tumor 1Appendiceal Neoplasms 1Abdominal Neoplasms 1

Interventions

Mitomycin 2Capecitabine 2Tacrolimus 1Specimen Handling 1Sirolimus 1Nivolumab 1Magnetic Resonance Spectroscopy 1Lansoprazole 1Ipilimumab 1Hyperthermic Intraperitoneal Chemotherapy 1Cytoreduction Surgical Procedures 1Clarithromycin 1CTLA-4 Antigen 1Bromelains 1Amoxicillin 1Alemtuzumab 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Pseudomyxoma Peritonei × Cytoreduction Surgical Procedures × Clear all
NCT02949791 2018-02-23

HIPEC-IAP

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Completed
38 enrolled
Gastrointestinal

Pseudomyxoma Peritonei, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡